Celon Pharma SA (CLN) — Free Cash Flow Generation Index

Latest as of December 2025: 1.76x

Celon Pharma SA (CLN) has a Free Cash Flow Generation Index of 1.76x as of December 2025. Free cash flow of zł64.59 Million represents 2% of operating cash flow (zł36.63 Million). See CLN current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.76x
Free Cash Flow / Operating CF

Free Cash Flow

zł64.59 Million
PLN

Operating Cash Flow

zł36.63 Million
PLN

Capital Expenditures

zł0.00
PLN

Celon Pharma SA Free Cash Flow Generation Index (2012–2025)

Historical FCF Generation Index trend for Celon Pharma SA across 10 annual periods. Explore Celon Pharma SA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Celon Pharma SA (2012–2025)

Year-by-year Free Cash Flow Generation Index for Celon Pharma SA. For the full company profile including market capitalisation, see market value of Celon Pharma SA.

Year FCG Index Free Cash Flow (PLN) Operating CF Capital Expenditures YoY Change
2025 1.00x zł23.85 Million zł23.85 Million zł0.00 ▲ +1590.5%
2021 0.06x zł2.60 Million zł43.95 Million zł41.35 Million ▲ +114.8%
2020 -0.40x zł-28.26 Million zł70.90 Million zł99.16 Million ▲ +71.3%
2018 -1.39x zł-39.22 Million zł28.24 Million zł67.46 Million ▼ -482.0%
2017 -0.24x zł-6.04 Million zł25.30 Million zł31.34 Million ▼ -668.4%
2016 -0.03x zł-641.17K zł20.65 Million zł21.29 Million ▼ -121.7%
2015 0.14x zł7.51 Million zł52.37 Million zł44.86 Million ▲ +92.7%
2014 0.07x zł1.81 Million zł24.36 Million zł22.55 Million ▼ -77.6%
2013 0.33x zł2.81 Million zł8.45 Million zł5.64 Million ▼ -49.8%
2012 0.66x zł8.52 Million zł12.87 Million zł4.34 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).